Two posters presented at the CHEST 2024 annual meeting highlighted significant disparities in acute coronary syndrome care ...

Because sickle cell disease isn’t as progressive a disease as others that have gene therapies available, there isn’t as much ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV ...

Many talks at the Association of Cancer Care Centers (ACCC) 41st National Oncology Conference advocated for the adoption of ...

Patients with low-count chronic lymphocytic leukemia phenotype monoclonal B-cell lymphocytosis had a 1.86-fold greater risk ...

Optune Lua creates tumor treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Chapa, MD, University of Nebraska Medical Center, brings awareness to the racial disparities demonstrated in his ...

The progress made to mitigate the opioid use crisis still pales in comparison with the crucial effort needed to address it, ...

Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...

There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s ...

The biosimilar market continued to grow, with 57 approved biosimilars and 17 reference product biologics as of June 2024. Biosimilars that have seen the fastest uptake have been in oncology, ...